Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders

Stem Cells

Volumn 28, Issue 9, 2010, Pages 1674-1685

  Lasagni, Laura ^a   Ballerini, Lara ^a   Angelotti, Maria Lucia ^a   Parente, Eliana ^a   Sagrinati, Costanza ^a   Mazzinghi, Benedetta ^a   Peired, Anna ^a   Ronconi, Elisa ^a   Becherucci, Francesca ^a   Bani, Daniele ^a   Gacci, Mauro ^a   Carini, Marco ^a   Lazzeri, Elena ^a   Romagnani, Paola ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Glomerulonephritis; Glomerulosclerosis; Kidney; Renal progenitors; Renal stem cells

Indexed keywords

NOTCH RECEPTOR; DIPEPTIDE; DOXORUBICIN; N (N (3,5 DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT BUTYL ESTER; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CELL; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; STEM CELL; ANIMAL; CASE CONTROL STUDY; CELL CULTURE; CELL CYCLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; GENETICS; HOSPITALIZATION; LUPUS ERYTHEMATOSUS NEPHRITIS; METABOLISM; MOUSE MUTANT; PATHOLOGY; TIME;

ANIMALS; CASE-CONTROL STUDIES; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; DIPEPTIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; LUPUS NEPHRITIS; MICE; MICE, SCID; PODOCYTES; PROTEINURIA; RECEPTORS, NOTCH; SEVERITY OF ILLNESS INDEX; STEM CELLS; TIME FACTORS; TRANSFECTION;

EID: 77957857754     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.492     Document Type: Article

References (53)

1. Szczech LA, Lazar IL. Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD. Kidney Int Suppl 2004;90:S3-S7.
2. Kwoh C, Shannon MB, Miner JH et al. Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol 2006;1:349-374.
3. Wiggins RC. The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 2007;71:1205-1214.
4. Kriz W, Lemley KV. The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens 1999;8:489-497.
5. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002;13:3005-3015.
6. Sagrinati C, Netti GS, Mazzinghi B et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006;17:2443-2456.
7. Lazzeri E, Crescioli C, Ronconi E et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol 2007;18:3128-3138.
8. Mazzinghi B, Ronconi E, Lazzeri E et al. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008;205:479-490.
9. Sagrinati C, Ronconi E, Lazzeri E et al. Stem-cell approaches for kidney repair: Choosing the right cells. Trends Mol Med 2008;14:277-285.
10. Ronconi E, Sagrinati C, Angelotti ML et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009;20:322-332.
11. Appel D, Kershaw D, Smeets B et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009;20:333-343.
12. Romagnani P. Toward the identification of a "renopoietic system"? Stem Cells 2009;27:2247-2253.
13. Smeets B, Angelotti ML, Rizzo P et al. Renal progenitor cells contribute to hyperplastic glomerular lesions of different types of podocytopathies and in crescentic glomerulonephritis. J Am Soc Nephrol 2009;20:2593-603.
14. Smeets B, Uhlig S, Fuss A et al. Parietal epithelial cells are the main component of glomerular extracapillary cellular lesions. J Am Soc Nephrol 2009;20:2604-2615.
15. Lazzeri E, Mazzinghi B, Romagnani P. Regeneration and the kidney. Curr Opin Nephrol Hypertens 2010;19:248-253.
16. Lasagni L, Romagnani P. Glomerular epithelial stem cells: The good, the bad and the ugly. J Am Soc Nephrol 2010 (in press).
17. Romagnani P. From Proteus to Prometheus: Learning from fish to modulate regeneration. J Am Soc Nephrol 2010;21:726-728.
18. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: Turning over new leaves. Cell 2007;128:445-458. (Pubitemid 46198895)
19. Fortini ME. Notch signalling: The core pathway and its posttranslational regulation. Dev Cell 2009;16:633-647.
20. Mizutani K, Yoon K, Dang L et al. Differential Notch signalling distinguishes neural stem cells from intermediate progenitors. Nature 2007;449:351-355.
21. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008;454:528-532.
22. Campa VM, Gutiérrez-Lanza R, Cerignoli F et al. Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. J Cell Biol 2008;183:129-141.
23. Romagnani P, Annunziato F, Lasagni L et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001;107:53-63.
24. Lasagni L, Francalanci M, Annunziato F et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med 2003;197:1537-1549.
25. Kita A, Imayoshi I, Hojo M et al. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol 2007;21:1458-1466. (Pubitemid 46984750)
26. Woo SM, Kim J, Han HW et al. Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells. BMC Neurosci 2009;10:97-108.
27. Varnum-Finney B, Dallas MH, Kato K et al. Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus. Blood 2008;111:2615-2620.
28. Pippin J, Durvasula R, Petermann A et al. DNA damage is a novel response to sublytic C5b-9-induced injury in podocytes. J Clin Invest 2003;111:877-885. (Pubitemid 37074963)
29. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005;67:404-419.
30. Lee VW, Wang Y, Qin X et al. Adriamycin nephropathy in severe combined immunodeficient (SCID) mice. Nephrol Dial Transplant 2006;21:3293-3298.
31. Shankland SJ, Floege J, Thomas SE et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 1997;52:404-413.
32. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001;108:807-816. (Pubitemid 32880291)
33. Schiffer M, Schiffer LE, Gupta A et al. Inhibitory Smads and TGF-β signalling in glomerular cells. J Am Soc Nephrol 2002;13:2657-2666.
34. Kroemer G, Galluzzi L, Vandenabeele P et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009;16:3-11.
35. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ 2008;15:1153-1162.
36. Kriz W, Hähnel B, Rösener S et al. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 1995;48:1435-1450.
37. Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 1992;42:148-160.
38. Huang XR, Holdsworth SR, Tipping PG. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 1994;46:69-78.
39. Tenschert S, Elger M, Lemley KV. Glomerular hypertrophy after subtotal nephrectomy: Relationship to early glomerular injury. Virchows Arch 1995;426:509-517.
40. Nagata M, Yamaguchi Y, Komatsu Y et al. Mitosis and presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 1995;70:68-71.
41. Olsen S. Extracapillary glomerulonephritis: A semiquantitative light-microscopical study of 59 patients. Acta Pathol Microbiol Scand Suppl 1974;249:7-19.
42. Lewis EJ, Cavallo T, Harrington JT et al. An immuno-pathologic study of rapidly progressive glomerulonephritis in the adult. Hum Pathol 1971;2:185-208.
43. Spear G. The proximal tubule and the podocyte in cystinosis. Nephron 1973;10:57-60.
44. Glotzer M. The molecular requirements for cytokinesis. Science 2005;307:1735-1739.
45. Faul C, Asanuma K, Yanagida-Asanuma E et al. Actin up: Regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007;17:428-437. (Pubitemid 47499042)
46. Verma R, Kovari I, Soofi A et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006;116:1346-1359.
47. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006;116:288-296.
48. Remuzzi G, Remuzzi A. Is regression of chronic nephropathies a therapeutic target? J Am Soc Nephrol 2005;16:840-842.
49. Morrissey J, Guo G, Moridaira K et al. Transforming growth factorbeta induces renal epithelial jagged-1 expression in fibrotic disease. J Am Soc Nephrol 2002;13:1499-508.
50. Niranjan T, Bielesz B, Gruenwald A et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008;14:290-298.
51. Abbate M, Zoja C, Morigi M et al. Transforming growth factor beta is upregulated by podocytes in response to excess intraglomerular passage of proteins: A central pathway in progressive glomerulosclerosis. Am J Pathol 2002;161:2179-2193.
52. Waters AM, Wu MY, Onay T et al. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol 2008;19:1139-1157.
53. Niranjan T, Murea M, Susztak K. The pathogenic role of notch activation in podocytes. Nephron Exp Nephrol 2009;111:e73-e79.